Search
for
Sort by
Research 631–660 of 1000+
- Challenging Regional Psoriasis and Ustekinumab Biotherapy: Impact of the Patterns of Disease
- RSPO1-mutated keratinocytes from palmoplantar keratoderma display impaired differentiation, alteration of cell–cell adhesion, EMT-like phenotype and invasiveness properties: implications for squamous cell carcinoma susceptibility in patients with 46XX disorder of sexual development
- Dietary Habits in Japanese Patients with Alopecia Areata
- Vitamin E-induced coagulopathy in a young patient: a case report
- Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Increased CRHR1 expression on monocytes from patients with AA enables a pro‐inflammatory response to corticotrophin‐releasing hormone
- Effective Role of Cytotoxic CD8+ T Cell in Iraqi Alopecia areata Patients
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Risk Analysis of Lurasidone in Patients with Schizophrenia and Bipolar Depression
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Vitamin D levels in patients with seborrheic dermatitis
- Low Level Laser versus Platelet-rich Plasma in Treatment of Alopecia Areata: A Randomized Controlled Intra-patient Comparative Study
- MicroRNA-mediated regulation of hair follicle regeneration: mechanisms, delivery strategies, and translational perspectives
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Evaluation of NF-κB as a Novel Serum Biomarker in Androgenetic Alopecia Patients: A Case–Control Study
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Cancer prevalence after exposure to Wnt-activating drugs: a systematic review
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- Scalp Bacterial Profile and Antibiotics Susceptibility Pattern in Patients With Primary Cicatricial Alopecia
- Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients.
- Commonly encountered symptoms and their management in patients with cirrhosis
- Psychological stress impact neurotrophic factor levels in patients with androgenetic alopecia and correlated with disease progression
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Satisfaction of Patients with Androgenetic Alopecia from a Topical Treatment with TH07 - A New Novel Combination of Substances that Safely Encourage Hair Growth